Exagen financials
$8.30−2.12%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $66.6M | $55.6M | $52.5M | $45.6M | $48.3M | $42.0M | $40.4M |
| Gross profit | $38.8M | $33.1M | $29.5M | $21.3M | $27.7M | $25.4M | $21.6M |
| Gross margin | 58.3% | 59.5% | 56.1% | 46.9% | 57.4% | 60.6% | 53.4% |
| Operating income | -$14.1M | -$13.6M | -$22.8M | -$46.1M | -$24.1M | -$15.2M | -$9.3M |
| Net income | -$20.0M | -$15.1M | -$23.7M | -$47.4M | -$26.9M | -$16.7M | -$30.3M |
| Net margin | −30.0% | −27.2% | −45.1% | −104.0% | −55.6% | −39.8% | −75.0% |
| Diluted EPS | $-0.93 | $-0.83 | $-1.34 | $-2.77 | $-1.68 | $-1.32 | $-8.46 |
| EBITDA | -$12.0M | -$11.9M | -$20.7M | -$39.0M | -$23.1M | -$14.6M | -$8.7M |
| Operating cash flow | -$13.6M | -$13.3M | -$14.5M | -$32.1M | -$20.3M | -$14.1M | -$9.7M |
| Free cash flow | -$14.3M | -$13.8M | -$15.3M | -$36.5M | -$22.7M | -$14.5M | -$10.1M |
| Diluted shares | 21.6M | 18.2M | 17.7M | 17.1M | 16.0M | 12.6M | 3.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $32.2M | $22.0M | $36.5M | $62.4M | $99.4M | $57.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $26.0M | $20.6M | $19.5M | $29.0M | $27.5M | $26.7M |
| Total assets | $58.0M | $44.7M | $56.9M | $86.2M | $123.4M | $78.4M |
| Total liabilities | $40.6M | $35.1M | $34.3M | $43.8M | $38.5M | $36.5M |
| Shareholders' equity | $17.4M | $9.5M | $22.7M | $42.5M | $84.9M | $41.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology